This page lists the hematology hospitals in our directory offering Multiple Myeloma Treatment in Delhi NCR, India, including Apollo Hospitals, Medanta - The Medicity, Artemis Hospital, Fortis Memorial Research Institute and others. Each listing links through to the hospital's full profile page.
Ask us about multiple myeloma treatment in Delhi NCR, India
Share a few details and our care coordination team will get back to you with next steps.
Top Hospitals for Multiple Myeloma Treatment in Delhi NCR, India
🇮🇳 Apollo Hospitals
Patients considering multiple myeloma treatment can be cared for by Apollo Hospitals's care team in New Delhi, India, from initial consultation through recovery. Apollo Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing multiple myeloma treatment.
🇮🇳 Medanta - The Medicity
Patients considering multiple myeloma treatment can be cared for by Medanta - The Medicity's care team in Gurgaon, India, from initial consultation through recovery. Medanta - The Medicity, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing multiple myeloma treatment.
🇮🇳 Artemis Hospital
Patients considering multiple myeloma treatment can be cared for by Artemis Hospital's care team in Gurgaon, India, from initial consultation through recovery. Artemis Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing multiple myeloma treatment.
🇮🇳 Fortis Memorial Research Institute
Patients considering multiple myeloma treatment can be cared for by Fortis Memorial Research Institute's care team in Gurgaon, India, from initial consultation through recovery. Fortis Memorial Research Institute, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing multiple myeloma treatment.
🇮🇳 Max Super Specialty Hospital
Patients considering multiple myeloma treatment can be cared for by Max Super Specialty Hospital's care team in New Delhi, India, from initial consultation through recovery. Max Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing multiple myeloma treatment.
🇮🇳 All India Institute of Medical Sciences (AIIMS)
Patients considering multiple myeloma treatment can be cared for by All India Institute of Medical Sciences (AIIMS)'s care team in New Delhi, India, from initial consultation through recovery. All India Institute of Medical Sciences (AIIMS), accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing multiple myeloma treatment.
🇮🇳 CK Birla Hospital
Patients considering multiple myeloma treatment can be cared for by CK Birla Hospital's care team in Gurugram, Haryana, India, from initial consultation through recovery. CK Birla Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing multiple myeloma treatment.
🇮🇳 Centre for Sight
Patients considering multiple myeloma treatment can be cared for by Centre for Sight's care team in Safdarjung Enclave, New Delhi, India, from initial consultation through recovery. Centre for Sight, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing multiple myeloma treatment.
🇮🇳 Max Super Specialty Hospital, Gurgaon
Patients considering multiple myeloma treatment can be cared for by Max Super Specialty Hospital, Gurgaon's care team in Gurgaon, India, from initial consultation through recovery. Max Super Specialty Hospital, Gurgaon, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing multiple myeloma treatment.
🇮🇳 Max Super Speciality Hospital, Patparganj
Patients considering multiple myeloma treatment can be cared for by Max Super Speciality Hospital, Patparganj's care team in Patparganj, New Delhi, India, from initial consultation through recovery. Max Super Speciality Hospital, Patparganj, accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing multiple myeloma treatment.
Top Hematology Doctors in Delhi NCR, India
Dr. Rahul Bhargava
- 20+ years of experience in Hematologist & BMT Specialist
- Principal Director – Hemato-Oncology, Fortis Memorial Research Institute, Gurugram
- Head of Hematology and BMT, Artemis Hospital, Gurugram
- Autologous Bone Marrow Transplant
- Allogeneic Bone Marrow Transplant
- Haploidentical BMT
- Unrelated Donor BMT
- Peripheral Blood Stem Cell Transplantation

Dr. Arun Singh Danewa
- 10+ years of experience in Pediatric Hematologist & BMT Specialist
- Senior Consultant — Pediatric Hematology, Oncology, Bone Marrow Transplant, Artemis Hospital, Gurugram
- Pediatric Oncology Fellowship, Sir Ganga Ram Hospital, New Delhi
- Allogeneic Bone Marrow Transplant
- Autologous Bone Marrow Transplant
- Haploidentical Stem Cell Transplant
- Matched Sibling Donor Transplant for Thalassemia
- Bone Marrow Aspiration & Biopsy

Dr. Gaurav Dixit
- 17+ years of experience in Hematologist & BMT Specialist
- Head — Haematology Oncology & Bone Marrow Transplant (Unit II), Artemis Hospital, Gurugram
- Senior Consultant — Haematology & BMT, Action Cancer Hospital, Delhi
- Autologous Stem Cell Transplant
- Matched Sibling Allogeneic Stem Cell Transplant
- Haploidentical Stem Cell Transplant
- Matched Unrelated Donor Transplant
- Bone Marrow Aspiration & Biopsy

Dr. Vikas Dua
- 20+ years of experience in Pediatric Hematologist & BMT Specialist
- Principal Director & Head — Paediatric Haematology, Haemato-Oncology and BMT, Fortis Memorial Research Institute, Gurgaon
- Senior Consultant — Paediatric Hemato-Oncology and BMT, Artemis Hospital, Gurgaon
- Allogeneic Bone Marrow Transplant
- Matched Sibling Donor Transplant
- Matched Unrelated Donor Transplant
- Haploidentical Paediatric Stem Cell Transplant
- Autologous Stem Cell Transplant
Dr. Rayaz Ahmed
- 20+ years of experience in Hematologist & BMT Specialist
- Director — Hematology & Bone Marrow Transplantation, Max Super Speciality Hospital, Saket, New Delhi
- Senior Consultant — Department of Hematology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi
- Autologous bone marrow / peripheral blood stem cell transplant
- Allogeneic matched sibling donor stem cell transplant
- Haplo-identical stem cell transplant
- Matched unrelated donor stem cell transplant
- Bone marrow aspiration and biopsy

Dr. Ajay Gupta
- 17+ years of experience in Hematologist & Bone Marrow Transplant Specialist
- Senior Consultant — Hematology, Indraprastha Apollo Hospital, New Delhi — Present
- Specialist in Bone Marrow Transplantation and Leukemia Management — Indraprastha Apollo Hospital, New Delhi
- Allogeneic Bone Marrow Transplantation
- Autologous Stem Cell Transplantation
- Haploidentical Bone Marrow Transplantation
- Peripheral Blood Stem Cell Mobilization and Harvesting
- Pediatric Bone Marrow Transplantation
How we selected these hospitals
A hospital appears on this page when Hematology is among its listed specialties and it is located in Delhi NCR, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Multiple Myeloma Treatment in Delhi NCR, India?
Choosing the right hospital for multiple myeloma treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include hematology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Multiple Myeloma Treatment
Multiple Myeloma is a malignancy of plasma cells in the bone marrow, and modern treatment protocols — including VRd (Bortezomib, Lenalidomide, Dexamethasone) induction, Autologous Stem Cell Transplantation (ASCT), and Daratumumab-based regimens — have transformed it from a rapidly fatal disease into a manageable, often remission-sustaining condition, with 5-year survival rates exceeding 55–60% in transplant-eligible patients at high-volume centers.
Clinical Overview
- Multiple Myeloma (MM) is a clonal plasma cell neoplasm in which malignant plasma cells proliferate within the bone marrow, crowding out normal hematopoietic cells and producing dysfunctional monoclonal immunoglobulins (M-protein or paraprotein).
- This pathological cascade results in the hallmark CRAB criteria: hyperCalcemia, Renal insufficiency (from cast nephropathy and light-chain deposition), Anemia (normocytic, normochromic due to marrow infiltration), and Bone lesions (osteolytic lesions driven by RANKL-mediated osteoclast activation and suppressed osteoblast activity).
- Beyond CRAB features, patients frequently present with recurrent infections due to humoral immunosuppression, peripheral neuropathy, and fatigue.
Who is a Candidate?
- ELIGIBILITY FOR TRANSPLANT-ELIGIBLE PATHWAY (VRd → ASCT → Maintenance):
- Age typically ≤70 years (physiological age assessed over chronological age; fit patients up to 75 may qualify after geriatric oncology evaluation)
- Confirmed diagnosis of symptomatic Multiple Myeloma per IMWG 2014 criteria (presence of CRAB criteria or SLiM criteria: ≥60% clonal plasma cells, sFLC ratio ≥100, >1 focal lesion on MRI)
- ECOG Performance Status 0–2
- +24 more
Treatment Options & Approaches
- INDUCTION THERAPY — VRd (STANDARD TRIPLET) AND DARA-VRd (QUADRUPLET, PREFERRED FOR HIGH-RISK OR FIT PATIENTS):
Recovery
- PHASE 1 — PRE-TREATMENT WORKUP AND PLANNING (Weeks 1–2): Upon arrival, GAF Healthcare coordinates same-day or next-day specialist consultation with a dedicated Myeloma Program hematologist/oncologist.
- All diagnostic tests listed (bone marrow biopsy, FISH cytogenetics, PET-CT/WBCT, ECHO, PFTs, SPEP/IFE, sFLC, full biochemistry) are completed within 5–7 business days at the hospital.
- R-ISS staging is determined, transplant eligibility is formally assessed by a multidisciplinary tumor board (hematology, transplant physician, cardiology, nephrology), and a personalized treatment plan — including regimen selection (VRd vs.
Risks to be aware of
- Multiple Myeloma treatment with VRd, ASCT, and Daratumumab carries a spectrum of procedure-specific and drug-specific risks that patients must understand prior to initiating therapy.
- ASCT-related mortality at experienced high-volume centers is now <1–2% (Treatment-Related Mortality, TRM), but the procedure carries significant morbidity during the aplastic phase.
Why GAF Healthcare
- GAF Healthcare provides comprehensive end-to-end non-medical support designed specifically for the complexities of a prolonged oncology treatment journey involving multiple hospital phases, outpatient cycles, and extended country stays.
Common questions about Multiple Myeloma Treatment
What is the cost of Multiple Myeloma Treatment (VRd, ASCT, and Daratumumab) in India vs. the UAE?
How long do I need to stay in the country before I am fit to fly home after Multiple Myeloma treatment?
What is the success rate of Multiple Myeloma treatment with VRd, ASCT, and Daratumumab?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Multiple Myeloma Treatment in Delhi NCR, India
Discover the Top Hospitals for Multiple Myeloma Treatment in Delhi NCR, India
This page lists 35 accredited hematology hospitals in Delhi NCR, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Patient Success Story
Frequently asked questions about multiple myeloma treatment in Delhi NCR, India
How many hematology hospitals are listed in Delhi NCR, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there hematology hospitals for this in other India cities?
Are these hospitals internationally accredited?
Can I get a treatment plan and cost estimate before I travel?
Do you help with visa, travel and accommodation?
What support do I get during and after treatment?
What does the "Featured" label next to a hospital's name mean?
How do I get matched with the right hospital for multiple myeloma treatment?
Does the listed cost cover everything?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for multiple myeloma treatment in Delhi NCR, India.
Contact us to report an inaccuracy on this page.
